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Edited by Felix WielandAbstract An O-3-hexose derivative, shown previously to inhibit
a malaria parasite hexose transporter expressed in Xenopus
oocytes as well as to suppress the multiplication of parasites,
both in vitro and in vivo, was shown here to block the uptake of
hexose sugars into isolated blood-stage parasites. This led to a
decline in ATP levels and the loss of intracellular pH control.
The results are consistent with those obtained with the cloned
transporter. They support the notion that the transporter
mediates uptake of glucose into the intraerythrocytic parasite
and provide further support for the view that it is a suitable
antimalarial drug target.
 2004 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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The intraerythrocytic malaria parasite relies on anaerobic
metabolism (glycolysis) to maintain its intracellular ATP
concentration. Glucose uptake into the most virulent human
malaria parasite, Plasmodium falciparum, is a saturable,
equilibrative process [1,2] and has been attributed to PfHT (P.
falciparum hexose transporter; [3–6]). PfHT is encoded by a
single copy gene belonging to the Major Facilitator Super-
family of transporters, with orthologues in mammalian cells. It
is localised to the parasite plasma membrane and, when ex-
pressed in Xenopus oocytes, transports both glucose and
fructose [3,4]. A recent study in which a range of O-3-hexose
derivatives were tested for their eﬀects on PfHT expressed in
Xenopus oocytes identiﬁed a number of eﬀective inhibitors of
the transporter [6]. One of these, a long chain O-3-hexose de-
rivative (compound 3361; 3-O-((undec-10-en)-yl)-D-glucose),
which showed selective inhibition of PfHT relative to several
mammalian sugar transporters, inhibited both the growth of
P. falciparum parasites in vitro and the proliferation of the
murine parasite, Plasmodium berghei, in vivo [6]. It was pos-
tulated that the antiplasmodial eﬀect of this compound was
due to inhibition of PfHT and the consequent deprivation of
the parasite of D-glucose. Glucose and fructose antagonised
the inhibition of parasite growth by compound 3361, consis-* Corresponding author. Fax: +61-2-6125-0313.
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than unrelated pathways. However, direct inhibition by 3361
of hexose uptake by the parasite and the consequent disruption
of parasite energetics have not been demonstrated.
In this study, we have investigated the eﬀect of compound
3361 on the uptake of hexose sugars into mature, trophozoite-
stage parasites ‘isolated’ from their host cells using a saponin-
permeabilisation technique. We show that compound 3361 is
an eﬀective inhibitor of hexose transport across the parasite
plasma membrane and that its addition to a parasite suspen-
sion leads to a rapid decline in ATP and a consequent loss of
pH control in both the parasite cytosol and the parasite’s in-
ternal ‘digestive vacuole’, a lysosomal compartment which
plays a key role in the metabolism of the parasite.2. Materials and methods
2.1. Parasite culture and isolation
All experiments were carried out using the 3D7 strain of P. falci-
parum at the mature trophozoite-stage (36–40 h post-invasion). The
parasites were cultured in Group O, Rhþ erythrocytes and synchron-
ised as described elsewhere [7].
Parasites were ‘isolated’ from their host erythrocytes using saponin
as described elsewhere [8]. Saponin renders the erythrocyte and par-
asitophorous vacuole membranes permeable to macromolecules [9] but
leaves the parasite plasma membrane intact and able to maintain
transmembrane ion gradients [8,10] and a substantial membrane po-
tential [7]. For the purpose of all the experiments reported here, the
isolated parasites were suspended in a HEPES-buﬀered saline con-
taining 125 mM NaCl, 5 mM KCl, 1 mM MgCl2 and 25 mM HEPES,
pH 7.1, at 37 C. Unless speciﬁed otherwise, the medium contained 5
mM glucose.
2.2. Hexose uptake measurements
Uptake of [14C]3-O-methylglucose ([14C]3OMG) and [14C]2-deoxy-
glucose ([14C]2DOG) into isolated parasites and the phosphorylation
of [14C]2DOG in parasite lysates were monitored using the methods
described previously for pantothenic acid [8,11]. ‘Distribution ratios’
(i.e., the ratio of the estimated intracellular concentration of radiolabel
relative to the extracellular concentration) were calculated as described
previously [8] using a value of 28 ﬂ for the H2O volume of an indi-
vidual parasite.
2.3. Measurement of intracellular ATP
ATP levels in isolated parasites were measured using the luciferin/
luciferase assay as described previously [1,12].
2.4. Measurement of cytosolic and digestive vacuole pH
The pH of the parasite cytosol (pHcyt) was measured using the ra-
tiometric pH-sensitive ﬂuorescent indicator 20,70-bis-(2-carboxyethyl)-blished by Elsevier B.V. All rights reserved.
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ﬂuorometer, as described previously [12].
Changes in the pH of the parasite’s acidic digestive vacuole were
monitored using a membrane-impermeant dextran-linked form of the
ﬂuorescent pH indicator ﬂuorescein, loaded into the digestive vacuole
by its incorporation into uninfected erythrocytes prior to their invasion
by the parasite as described previously [13].
2.5. Reagents
Compound 3361 [6] was obtained from Dr. Christophe Morin
(Laboratoire d’Etudes Dynamiques et Structurales de la Selectivite,
Universite Joseph-Fourier Grenoble, France). It was added to cell
suspensions as a methanol solution, with appropriate solvent controls
carried out in each case. [14C]3OMG was from Amersham, [14C]2DOG
was from NEN, and BCECF and dextran-linked ﬂuorescein were from
Molecular Probes. All other reagents were of analytical grade.3. Results
In initial measurements of the uptake of the non-metaboli-
sable hexose [14C]3OMG by isolated parasites in glucose-free
medium, it was found that the sugar equilibrated rapidly
across the parasite plasma membrane, reaching an estimated
distribution ratio of approximately 1.2 within 20 s (Fig. 1A).
Addition of compound 3361 at a concentration of 200 lM
(some four-fold higher than the Ki for inhibition of glucose
transport via PfHT, expressed in oocytes; [6]) caused a marked
reduction in the rate of equilibration (Fig. 1A); the estimated
distribution ratios at 20 s and 1 min were signiﬁcantly lower in
the presence of compound 3361 than under control conditions
(P < 0:001 and P ¼ 0:012, respectively; paired t-test). How-
ever, quantitation of the degree of inhibition of the transport
rate was made diﬃcult by the very fast transport under the
conditions of the experiment, and the technical problems as-
sociated with measuring the uptake of a solute which equili-
brates between the intra-and extracellular solutions under
conditions in which up to two-thirds of the volume of the cell
pellet was in the extracellular solution.
Another hexose analogue, [14C]2DOG, oﬀers signiﬁcant
advantages as a probe of hexose uptake into the parasite as, onFig. 1. (A) Uptake of [14C]3OMG by isolated P. falciparum trophozoites in th
lM). The parasites were suspended in HEPES-buﬀered glucose-free saline fo
from three experiments and are shown S.E.M. The asterisks denote signiﬁca
P < 0:001; P ¼ 0:012 (paired t-test). (B) Uptake of [14C]2DOG by isolate
(closed circles) of compound 3361 (200 lM). The parasites were suspended
averaged from a single experiment with duplicate samples (error bars repres
obtained in three similar experiments. (C) Phosphorylation of [14C]2DOG in a
of compound 3361 (200 lM), or in the presence of 10 mM glucose (closed tria
MgCl2 and 5 mM ATP, pH 7.4. The data are averaged from a single experim
shown, fall within the symbols) and are representatives of those obtained inentering the cell, it is phosphorylated and thereby trapped in
the cytosol, causing the accumulation of radiolabel to con-
centrations well above that in the extracellular medium [1].
Fig. 1B shows time-courses for the uptake of [14C]2DOG by
isolated parasites in the presence and absence of compound
3361. In the absence of the inhibitor, the radiolabel accumu-
lated to an intracellular concentration >25-fold higher than
the extracellular concentration within 3 min. In parasites
treated with compound 3361 (200 lM), the initial rate of ac-
cumulation was decreased by >95%.
The pronounced inhibition of [14C]2DOG uptake by com-
pound 3361 may be due to an eﬀect of the reagent on the
transport mechanism and/or on the phosphorylation of
[14C]2DOG by hexokinase. The eﬀect of compound 3361 on
the phosphorylation of [14C]2DOG was tested directly using
parasite lysates. As shown in Fig. 1C, [14C]2DOG phosphor-
ylation by lysate prepared from isolated P. falciparum troph-
ozoites was not aﬀected signiﬁcantly by 200 lM of compound
3361. By contrast, the initial rate of phosphorylation was re-
duced by >95% by the addition to the medium of unlabelled
glucose (10 mM) which acts as a competitive inhibitor of
[14C]2DOG phosphorylation.
The failure of compound 3361 to inhibit [14C]2DOG phos-
phorylation indicates that the decreased uptake of [14C]2DOG
into isolated parasites in the presence of compound 3361 is
attributable to the inhibition of the transport of the hexose by
the compound across the parasite plasma membrane.
Fig. 2 illustrates the biochemical consequences of the ad-
dition of the hexose transport inhibitor for the parasite. As
shown in Fig. 2A, on addition of 200 lM of compound 3361
to isolated parasites suspended in a medium containing 5 mM
glucose, the [ATP] decreased to <20% of its normal resting
value within 10 min. The inhibitor also caused a rapid de-
crease in pHcyt (Fig. 2B) and a slower increase in the pH of
the parasite’s digestive vacuole (Fig. 2C). As shown in Fig. 3,
the rate of acidiﬁcation of the parasite cytosol, immediately
following the addition of the inhibitor, increased with in-
creasing concentration of compound 3361 (Fig. 3A) and de-e presence (open bars) or absence (closed bars) of compound 3361 (200
r 15 min prior to the addition of [14C]3OMG. The data are averaged
nt diﬀerences between uptake in the presence and absence of inhibitor:
d P. falciparum trophozoites in the presence (open circles) or absence
in HEPES-buﬀered saline containing 200 lM glucose. The data are
enting range/2 fall within the symbols) and are representative of those
parasite lysate in the presence (open circles) or absence (closed circles)
ngles). The lysate was diluted in medium containing 50 mM Tris, 5 mM
ent with duplicate samples (error bars represent range/2 and, where not
three similar experiments.
Fig. 2. Eﬀect of compound 3361 (200 lM, in methanol) on (A) ATP levels in isolated parasites, (B) pHcyt and (C) the pH in the digestive vacuole. In
each case, the parasites were suspended in HEPES-buﬀered saline containing 5 mM glucose. The ATP data (A) are averaged from those obtained in
three independent experiments and are shown S.E.M. The pHcyt data (B) are representatives of those obtained in three independent experiments.
The digestive vacuole pH data are expressed in terms of the ﬂuorescence ratio arising from dextran-linked ﬂuorescein loaded into the digestive
vacuole. The sample was excited at 490 and 450 nm successively, and the ﬂuorescence was measured at 520 nm. The ratio of the ﬂuorescence intensity
measured using the two excitation wavelengths (490/450 nm) provides an indicator of digestive vacuole pH, with an increase in the ﬂuorescence ratio
(i.e., an upward deﬂection of the trace) indicating an alkalinisation. In solvent controls, the addition of an equivalent volume of methanol (in the
absence of inhibitor) had no eﬀect on any of the three parameters measured (not shown).
Fig. 3. (A) Concentration-dependence of the eﬀect of compound 3361 on the initial rate of acidiﬁcation of the parasite cytosol following the addition
of compound 3361 to parasites suspended in medium containing 5 mM glucose. The conditions were as for Fig. 2B. (B) Eﬀect of increasing glucose
concentration on the initial rate of acidiﬁcation of the parasite cytosol following the addition of 200 lM of compound 3361. In both cases, the data
are averaged from three independent experiments and are shown S.E.M.
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medium (Fig. 3B).4. Discussion
The intraerythrocytic malaria parasite is reliant on the up-
take of hexose sugar from the external medium to fuel gly-
colysis and thereby generates ATP. Glucose traverses the host
erythrocyte membrane rapidly via the endogenous erythrocyte
glucose transporter as well as, much more slowly, via the ‘new
permeability pathways’ induced by the parasite in the host cell
membrane [1,2,14,15]. From the red cell cytosol it crosses the
‘parasitophorous vacuole membrane’ enclosing the intracellu-
lar parasite, presumably via the high-capacity pores that are
thought to render this membrane freely permeable to low
molecular weight solutes [16]. Having gained access to the
parasitophorous vacuole, it is taken up via transporters in the
parasite plasma membrane.
Previous measurements on the transport of hexose sugars in
intact P. falciparum-infected erythrocytes yielded data consis-
tent with the view that the transport of sugars into the intra-
cellular parasite is an equilibrative (rather than aconcentrative) process [1], mediated via a saturable carrier [2].
The subsequent cloning and characterisation of a PfHT lo-
calised to the vicinity of the intraerythrocytic parasite surface
[3] and showing saturation kinetics but little dependence on
either the extracellular Naþ concentration or extracellular pH
[5] lent support for this view, as well as providing the ﬁrst
detailed characterisation of a Plasmodium transporter [3,4].
In this study, the transport of hexose sugar across the par-
asite plasma membrane was monitored directly using parasites
isolated from their host erythrocyte by saponin-permeabilisa-
tion of the erythrocyte and parasitophorous vacuole mem-
branes; the analysis is therefore free of the complexities
associated with that of data derived from the intact parasitised
erythrocyte and its multiple membrane systems [1,2]. The
transport of the non-metabolisable glucose analogue
[14C]3OMG into the parasite was extremely fast, equilibrating
within 20 s (Fig. 1A). The observation that, at equilibrium, its
distribution ratio was close to 1 conﬁrms the conclusions from
the earlier study on intact parasitised cells that glucose trans-
port into the intracellular parasite is equilibrative rather than
accumulative in nature [1]. In the case of the phosphorylatable
glucose analogue [14C]2DOG, the observation that the con-
centration of radiolabel in isolated parasites was well in excess
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parasites and [14C]2DOG (i.e., by the ﬁrst timepoint in Fig. 1B)
is consistent with transport having been suﬃciently fast for the
hexose sugar to have equilibrated between the intra- and ex-
tracellular solutions within this time period. Addition of
compound 3361 caused a signiﬁcant inhibition of [14C]3OMG
transport and a marked inhibition of [14C]2DOG accumula-
tion, via a mechanism that was unrelated to an eﬀect on
phosphorylation (Fig. 1C) and which can therefore be attrib-
uted to an inhibition of the transporter. Compound 3361 has
already been shown to be an eﬀective inhibitor of PfHT ex-
pressed in Xenopus oocytes. These data therefore lend support
to the hypothesis [5] that PfHT is the major route of entry of
glucose into the intracellular parasite.
Compound 3361 has been shown previously to inhibit the in
vitro growth of P. falciparum, measured over a 48-h period, as
well as inhibiting the propagation of P. berghei parasites in
mice [6]. The data of Fig. 2 provide insights into the earliest
eﬀects of the compound on the parasite. Within seconds of its
addition, there is a decrease in the intracellular ATP concen-
tration (Fig. 2A). The parasite uses ATP to fuel Hþ-pumping
ATPases on both the parasite plasma membrane [12,17] and
the membrane of its internal digestive vacuole [13]. The decline
in [ATP] following the addition of compound 3361 resulted in
a loss of pH control in both the cytosolic and digestive vacuole
compartments: there was a rapid acidiﬁcation of the parasite
cytosol (Fig. 2B) and a slower alkalinisation of the digestive
vacuole (Fig. 2C). The cytosolic pH decreased to a value of
approximately 6.95 slightly below that in the extracellular so-
lution (7.1). The likely explanation for this is that under the
conditions of the experiment, the inhibitor did not completely
abolish glucose uptake and that although ATP levels decreased
suﬃciently to slow the plasma membrane and digestive vacuole
Hþ-ATPases there was still suﬃcient metabolism occurring to
generate a signiﬁcant acid load within the parasite. The ﬁnding
in Fig. 1A that hexose transport was not inhibited fully by
compound 3361 and in Fig. 2A that the parasite still retained a
signiﬁcant [ATP] in the presence of inhibitor are both consis-
tent with this interpretation.
Acidiﬁcation of the cytosol will interfere with the plethora of
metabolic processes taking place in this compartment, while
alkalinisation of the digestive vacuole will impede the action of
the various acid-dependent proteases that are needed to break
down the host cell haemoglobin in this compartment [18].
The inhibitor-induced acidiﬁcation of the parasite cytosol
was concentration-dependent (Fig. 3A) and reversed by in-
creasing concentration of glucose (Fig. 3B). The latter obser-
vation is consistent with inhibition of glucose permeation
rather than to unrelated eﬀects (e.g., direct inhibition of the Hþ
pumps or disruption of the membranes enclosing the relevant
compartments), and with the inhibition of the parasite’s hexose
transporter being competitive in nature.
The results of this study highlight the potential of the ma-
laria parasite’s hexose transporter as an antimalarial drug
target. Patients with severe malaria commonly become hypo-glycaemic [19]. The lower the extracellular glucose concentra-
tion, the more eﬀective the inhibitor will be at perturbing ion
homeostasis in the parasite (Fig. 3B); the eﬃcacy of such
compounds might therefore be expected to be enhanced in
patients with hypoglycaemia. Furthermore, selective inhibitors
of PfHT should not only kill the parasite but, by causing an
immediate inhibition of glucose uptake into the parasite while
leaving the GLUT1 transporter of the blood–brain barrier
unaﬀected [6], should prevent sequestered parasites from
competing with the brain for glucose, as may occur in cerebral
malaria [20].Acknowledgements: This work was supported by the Australian Na-
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